New study aims to sharpen cancer detection with Full-Body PET scans
NCT ID NCT05160480
First seen Jan 31, 2026 · Last updated May 20, 2026 · Updated 12 times
Summary
This study tests whether a new total-body PET scanner can improve cancer imaging for people with prostate cancer, breast cancer, or neuroendocrine tumors. Nine participants will receive one of three FDA-approved imaging agents to see how well the scanner captures tumor activity. The goal is to gather data to make future scans more accurate, not to treat the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UC Davis EXPLORER Molecular Imaging Center
Sacramento, California, 95816, United States
Conditions
Explore the condition pages connected to this study.